Resources

videos

Resources

publications

Therapeutic potential of stem cells for preterm infant brain damage: can we move from the heterogeneity of preclinical and clinical studies to established therapeutics?

Sofia Passera, Marta Boccazzi, Cindy Bokobza, Valerie Faivre, Fabio Mosca, Juliette Van Steenwinckel, Monica Fumagalli, Pierre Gressens and Bobbi Fleiss

Biochemical Pharmacology 2021, 114461; https://doi.org/10.3390/biom11010099

Received: 10 December 2020 / Revised: 27 January 2021 / Accepted: 2 February 2021 / Available online: 8 February 2021

Microglia-Mediated Neurodegeneration in Perinatal Brain Injuries

Bobbi Fleiss, Juliette Van Steenwinckel, Cindy Bokobza, Isabelle K. Shearer, Emily Ross-Munro and Pierre Gressens

Biomolecules 2021, 11(1), 99; https://doi.org/10.3390/biom11010099

Received: 29 November 2020 / Revised: 8 January 2021 / Accepted: 11 January 2021 / Published: 13 January 2021

This review looks at strategies developed experimentally to modulate microglia and reduce brain injury in babies. It focusses on four causes of perinatal brain injury which occur frequently in both westernised and emerging countries, including EoP and neonatal stroke, and reviews pharmacological approaches as well as novel nanoparticle mediated therapies.

Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key

Daan R.M.G. Ophelders, Ruth Gussenhoven, Luise Klein, Reint K. Jellema, Rob J.J. Westerlaken, Matthias C. Hütten, Jeroen Vermeulen, Guido Wassink, Alistair J. Gunn and Tim G.A.M. Wolfs

Cells 20209(8), 1871; https://doi.org/10.3390/cells9081871
 
Received: 8 June 2020 / Revised: 31 July 2020 / Accepted: 5 August 2020 / Published: 10 August 2020